Overview

• Federal Judge Ernesto Kreplak confirmed 76 fatalities linked to two contaminated fentanyl lots and estimated that about 45,000 ampoules from lot 31202 were administered before ANMAT banned their use
• Authorities recovered roughly 115,000 ampoules in coordinated raids and secured around 30,000 in hospital inventories, yet tens of thousands of doses remain unaccounted for
• Judicial actions include asset freezes and travel bans on 24 individuals tied to HLB Pharma and Laboratorios Ramallo, and both firms are barred from manufacturing or selling medications
• ANLIS-Malbrán’s ongoing genomic analyses aim to match Klebsiella pneumoniae and Ralstonia pickettii strains from patient samples to those found in the tainted vials
• Regulatory scrutiny intensified after ANMAT found HLB Pharma lacked a valid manufacturing authorization and had released lot 31202 just 17 days after production